Reinvestigating the clinical relevance of the m6A writer METTL3 in urothelial carcinoma of the bladder

METTL3 is the major writer of N6-Methyladenosine (m6A) and has been associated with controversial roles in cancer. This is best illustrated in urothelial carcinoma of the bladder (UCB), where METTL3 was described to have both oncogenic and tumor-suppressive functions. Here, we reinvestigated the rol...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Koch, Jonas (VerfasserIn) , Neuberger, Manuel (VerfasserIn) , Schmidt-Dengler, Martina (VerfasserIn) , Xu, Jinyun (VerfasserIn) , Coutinho Carneiro, Vitor (VerfasserIn) , Ellinger, Jörg (VerfasserIn) , Kriegmair, Maximilian (VerfasserIn) , Nuhn, Philipp (VerfasserIn) , Erben, Philipp (VerfasserIn) , Michel, Maurice Stephan (VerfasserIn) , Helm, Mark (VerfasserIn) , Rodríguez Paredes, Manuel (VerfasserIn) , Nientiedt, Malin (VerfasserIn) , Lyko, Frank (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: 18 August 2023
In: iScience
Year: 2023, Jahrgang: 26, Heft: 8, Pages: 1-17
ISSN:2589-0042
DOI:10.1016/j.isci.2023.107300
Online-Zugang:Verlag, kostenfrei, Volltext: https://doi.org/10.1016/j.isci.2023.107300
Verlag, kostenfrei, Volltext: https://www.sciencedirect.com/science/article/pii/S2589004223013779
Volltext
Verfasserangaben:Jonas Koch, Manuel Neuberger, Martina Schmidt-Dengler, Jinyun Xu, Vitor Coutinho Carneiro, Jörg Ellinger, Maximilian C. Kriegmair, Philipp Nuhn, Philipp Erben, Maurice Stephan Michel, Mark Helm, Manuel Rodríguez-Paredes, Malin Nientiedt, and Frank Lyko

MARC

LEADER 00000caa a2200000 c 4500
001 1866216546
003 DE-627
005 20260105113158.0
007 cr uuu---uuuuu
008 231018s2023 xx |||||o 00| ||eng c
024 7 |a 10.1016/j.isci.2023.107300  |2 doi 
035 |a (DE-627)1866216546 
035 |a (DE-599)KXP1866216546 
035 |a (OCoLC)1425210092 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Koch, Jonas  |e VerfasserIn  |0 (DE-588)1306479746  |0 (DE-627)1866217070  |4 aut 
245 1 0 |a Reinvestigating the clinical relevance of the m6A writer METTL3 in urothelial carcinoma of the bladder  |c Jonas Koch, Manuel Neuberger, Martina Schmidt-Dengler, Jinyun Xu, Vitor Coutinho Carneiro, Jörg Ellinger, Maximilian C. Kriegmair, Philipp Nuhn, Philipp Erben, Maurice Stephan Michel, Mark Helm, Manuel Rodríguez-Paredes, Malin Nientiedt, and Frank Lyko 
246 3 3 |a Reinvestigating the clinical relevance of the m 6 A writer METTL3 in urothelial carcinoma of the bladder 
264 1 |c 18 August 2023 
300 |b Illustrationen 
300 |a 17 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Online verfügbar: 11. Juli 2023, Artikelversion: 27. Juli 2023 
500 |a Im Titel ist die Zahl 6 hochgestellt 
500 |a Gesehen am 18.10.2023 
520 |a METTL3 is the major writer of N6-Methyladenosine (m6A) and has been associated with controversial roles in cancer. This is best illustrated in urothelial carcinoma of the bladder (UCB), where METTL3 was described to have both oncogenic and tumor-suppressive functions. Here, we reinvestigated the role of METTL3 in UCB. METTL3 knockout reduced the oncogenic phenotype and m6A levels of UCB cell lines. However, complete depletion of METTL3/m6A was not achieved due to selection of cells expressing alternative METTL3 isoforms. Systematic vulnerability and inhibitor response analyses suggested that uroepithelial cells depend on METTL3 for viability. Furthermore, expression and survival analyses of clinical data revealed a complex role for METTL3 in UCB, with decreased m6A mRNA levels in UCB tumors. Our results suggest that METTL3 expression may be a suitable diagnostic UCB biomarker, as the enzyme promotes UCB formation. However, the suitability of the enzyme as a therapeutic target should be evaluated carefully. 
650 4 |a Biological sciences 
650 4 |a Cancer systems biology 
650 4 |a Epigenetics 
650 4 |a Molecular biology 
650 4 |a Molecular mechanism of gene regulation 
650 4 |a Natural sciences 
650 4 |a Oncology 
650 4 |a Systems biology 
700 1 |a Neuberger, Manuel  |e VerfasserIn  |0 (DE-588)118332331X  |0 (DE-627)1663137250  |4 aut 
700 1 |a Schmidt-Dengler, Martina  |e VerfasserIn  |4 aut 
700 1 |a Xu, Jinyun  |d 1995-  |e VerfasserIn  |0 (DE-588)137229001X  |0 (DE-627)1931684758  |4 aut 
700 1 |a Coutinho Carneiro, Vitor  |e VerfasserIn  |0 (DE-588)1246698145  |0 (DE-627)177975020X  |4 aut 
700 1 |a Ellinger, Jörg  |e VerfasserIn  |4 aut 
700 1 |a Kriegmair, Maximilian  |d 1987-  |e VerfasserIn  |0 (DE-588)1049742745  |0 (DE-627)782573347  |0 (DE-576)403726840  |4 aut 
700 1 |a Nuhn, Philipp  |d 1981-  |e VerfasserIn  |0 (DE-588)136112951  |0 (DE-627)694090808  |0 (DE-576)30083909X  |4 aut 
700 1 |a Erben, Philipp  |d 1973-  |e VerfasserIn  |0 (DE-588)128501014  |0 (DE-627)373920997  |0 (DE-576)297181661  |4 aut 
700 1 |a Michel, Maurice Stephan  |d 1970-  |e VerfasserIn  |0 (DE-588)121842568  |0 (DE-627)705674134  |0 (DE-576)29291363X  |4 aut 
700 1 |a Helm, Mark  |e VerfasserIn  |4 aut 
700 1 |a Rodríguez Paredes, Manuel  |e VerfasserIn  |0 (DE-588)1186002484  |0 (DE-627)1665289864  |4 aut 
700 1 |a Nientiedt, Malin  |d 1991-  |e VerfasserIn  |0 (DE-588)114835476X  |0 (DE-627)1008678988  |0 (DE-576)496269860  |4 aut 
700 1 |a Lyko, Frank  |e VerfasserIn  |0 (DE-588)1106120361  |0 (DE-627)862900018  |0 (DE-576)473860597  |4 aut 
773 0 8 |i Enthalten in  |t iScience  |d Amsterdam : Elsevier, 2018  |g 26(2023), 8 vom: Aug., Artikel-ID 107300, Seite 1-17  |h Online-Ressource  |w (DE-627)1019532106  |w (DE-600)2927064-9  |w (DE-576)502115858  |x 2589-0042  |7 nnas  |a Reinvestigating the clinical relevance of the m6A writer METTL3 in urothelial carcinoma of the bladder 
773 1 8 |g volume:26  |g year:2023  |g number:8  |g month:08  |g elocationid:107300  |g pages:1-17  |g extent:17  |a Reinvestigating the clinical relevance of the m6A writer METTL3 in urothelial carcinoma of the bladder 
856 4 0 |u https://doi.org/10.1016/j.isci.2023.107300  |x Verlag  |x Resolving-System  |z kostenfrei  |3 Volltext  |7 0 
856 4 0 |u https://www.sciencedirect.com/science/article/pii/S2589004223013779  |x Verlag  |z kostenfrei  |3 Volltext  |7 0 
951 |a AR 
992 |a 20231018 
993 |a Article 
994 |a 2023 
998 |g 1106120361  |a Lyko, Frank  |m 1106120361:Lyko, Frank  |d 50000  |e 50000PL1106120361  |k 0/50000/  |p 14  |y j 
998 |g 114835476X  |a Nientiedt, Malin  |m 114835476X:Nientiedt, Malin  |d 60000  |d 63100  |e 60000PN114835476X  |e 63100PN114835476X  |k 0/60000/  |k 1/60000/63100/  |p 13 
998 |g 1186002484  |a Rodríguez Paredes, Manuel  |m 1186002484:Rodríguez Paredes, Manuel  |d 50000  |e 50000PR1186002484  |k 0/50000/  |p 12 
998 |g 121842568  |a Michel, Maurice Stephan  |m 121842568:Michel, Maurice Stephan  |d 60000  |d 63100  |e 60000PM121842568  |e 63100PM121842568  |k 0/60000/  |k 1/60000/63100/  |p 10 
998 |g 128501014  |a Erben, Philipp  |m 128501014:Erben, Philipp  |d 60000  |e 60000PE128501014  |k 0/60000/  |p 9 
998 |g 136112951  |a Nuhn, Philipp  |m 136112951:Nuhn, Philipp  |d 60000  |d 63100  |e 60000PN136112951  |e 63100PN136112951  |k 0/60000/  |k 1/60000/63100/  |p 8 
998 |g 1049742745  |a Kriegmair, Maximilian  |m 1049742745:Kriegmair, Maximilian  |d 60000  |d 63100  |e 60000PK1049742745  |e 63100PK1049742745  |k 0/60000/  |k 1/60000/63100/  |p 7 
998 |g 1246698145  |a Coutinho Carneiro, Vitor  |m 1246698145:Coutinho Carneiro, Vitor  |d 50000  |e 50000PC1246698145  |k 0/50000/  |p 5 
998 |g 137229001X  |a Xu, Jinyun  |m 137229001X:Xu, Jinyun  |d 50000  |d 51001  |e 50000PX137229001X  |e 51001PX137229001X  |k 0/50000/  |k 1/50000/51001/  |p 4 
998 |g 118332331X  |a Neuberger, Manuel  |m 118332331X:Neuberger, Manuel  |d 60000  |d 63100  |e 60000PN118332331X  |e 63100PN118332331X  |k 0/60000/  |k 1/60000/63100/  |p 2 
998 |g 1306479746  |a Koch, Jonas  |m 1306479746:Koch, Jonas  |d 140000  |e 140000PK1306479746  |k 0/140000/  |p 1  |x j 
999 |a KXP-PPN1866216546  |e 4392059464 
BIB |a Y 
SER |a journal 
JSO |a {"recId":"1866216546","titleAlt":[{"title":"Reinvestigating the clinical relevance of the m 6 A writer METTL3 in urothelial carcinoma of the bladder"}],"person":[{"given":"Jonas","role":"aut","display":"Koch, Jonas","family":"Koch"},{"given":"Manuel","role":"aut","display":"Neuberger, Manuel","family":"Neuberger"},{"family":"Schmidt-Dengler","display":"Schmidt-Dengler, Martina","role":"aut","given":"Martina"},{"role":"aut","family":"Xu","display":"Xu, Jinyun","given":"Jinyun"},{"given":"Vitor","role":"aut","display":"Coutinho Carneiro, Vitor","family":"Coutinho Carneiro"},{"given":"Jörg","role":"aut","family":"Ellinger","display":"Ellinger, Jörg"},{"given":"Maximilian","display":"Kriegmair, Maximilian","family":"Kriegmair","role":"aut"},{"display":"Nuhn, Philipp","family":"Nuhn","role":"aut","given":"Philipp"},{"given":"Philipp","role":"aut","display":"Erben, Philipp","family":"Erben"},{"role":"aut","family":"Michel","display":"Michel, Maurice Stephan","given":"Maurice Stephan"},{"display":"Helm, Mark","family":"Helm","role":"aut","given":"Mark"},{"given":"Manuel","role":"aut","family":"Rodríguez Paredes","display":"Rodríguez Paredes, Manuel"},{"given":"Malin","family":"Nientiedt","display":"Nientiedt, Malin","role":"aut"},{"given":"Frank","role":"aut","display":"Lyko, Frank","family":"Lyko"}],"type":{"bibl":"article-journal","media":"Online-Ressource"},"note":["Online verfügbar: 11. Juli 2023, Artikelversion: 27. Juli 2023","Im Titel ist die Zahl 6 hochgestellt","Gesehen am 18.10.2023"],"name":{"displayForm":["Jonas Koch, Manuel Neuberger, Martina Schmidt-Dengler, Jinyun Xu, Vitor Coutinho Carneiro, Jörg Ellinger, Maximilian C. Kriegmair, Philipp Nuhn, Philipp Erben, Maurice Stephan Michel, Mark Helm, Manuel Rodríguez-Paredes, Malin Nientiedt, and Frank Lyko"]},"physDesc":[{"noteIll":"Illustrationen","extent":"17 S."}],"title":[{"title_sort":"Reinvestigating the clinical relevance of the m6A writer METTL3 in urothelial carcinoma of the bladder","title":"Reinvestigating the clinical relevance of the m6A writer METTL3 in urothelial carcinoma of the bladder"}],"language":["eng"],"origin":[{"dateIssuedKey":"2023","dateIssuedDisp":"18 August 2023"}],"id":{"eki":["1866216546"],"doi":["10.1016/j.isci.2023.107300"]},"relHost":[{"physDesc":[{"extent":"Online-Ressource"}],"language":["eng"],"title":[{"title":"iScience","title_sort":"iScience"}],"note":["Gesehen am 11.09.2018"],"origin":[{"publisher":"Elsevier","dateIssuedDisp":"[2018]-","publisherPlace":"Amsterdam ; Boston ; London ; New York ; Oxford ; Paris ; Philadelphia ; San Diego ; St. Louis"}],"id":{"zdb":["2927064-9"],"eki":["1019532106"],"issn":["2589-0042"]},"disp":"Reinvestigating the clinical relevance of the m6A writer METTL3 in urothelial carcinoma of the bladderiScience","part":{"text":"26(2023), 8 vom: Aug., Artikel-ID 107300, Seite 1-17","extent":"17","year":"2023","issue":"8","pages":"1-17","volume":"26"},"pubHistory":["Volume 1 (March 23, 2018)-"],"type":{"bibl":"periodical","media":"Online-Ressource"},"recId":"1019532106"}]} 
SRT |a KOCHJONASNREINVESTIG1820